INTRODUCTION
A usual source of care (USOC) is defined as a place where an individual most often goes if he or she is sick or needs personal health advice, such as a doctor's office, clinic, or health center. 1 Approximately 85 % of Americans selfreport having a USOC, 2 which has been associated with higher quality care. 3, 4 Having a USOC is associated with greater receipt of preventive services, 5, 6 less use of emergency department visits, 7, 8 and less engagement in risky behaviors. 9 Furthermore, a USOC is associated with improved management of chronic diseases such as HIV, 10 diabetes, 11 hypertension, 12 and hypercholesterolemia. 12 In contrast, individuals living in the community without a USOC are more likely to be hospitalized, less likely to see a physician when symptomatic, and delay seeking needed care. 13 Following an acute clinical event, one might expect having a USOC to be important, yet this has not been studied. Moreover, prior studies have lacked data to explore the quality of the relationship between a patient and their USOC and whether there is an association with outcomes.
To date, most studies have evaluated the presence of a USOC without accounting for potentially critical characteristics of the individual's relationship with the doctor or other health professional, hereafter referred to as clinician, or health center. Validated measures of communication and trust have been critical to informing the quality of the relationship between a patient and clinician and have been associated with medication adherence and overall satisfaction; however, from a policy level, they are difficult to promote. 14, 15 While no validated scales exist to evaluate the strength of the relationship with a USOC, further investigation may help us understand quality between a patient and a provider at the system level, which may be more conducive to change. A more detailed assessment of USOC may reveal important differences in the health systempatient relationship that may impact patient outcomes such as rehospitalization and mortality, particularly after an acute clinical event that requires regular follow-up.
In this study, we examine the presence and strength of the USOC relationship on a continuum and assess its association with outcomes following acute myocardial infarction (AMI), a common medical condition that is thought to require close follow-up care after discharge. Using data from the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery (PREMIER), a prospective registry of patients hospitalized with myocardial infarction, we were able to develop a novel, more detailed definition of USOC, taking into account the duration of the relationship, along with the patient's perspective of how well the USOC knew them and communicated with them. 16 Specifically, we compare the association between the strength of the USOC relationship and mortality and readmission following hospitalization.
METHODS

Sample and Study Design
We used data from all patients enrolled in PREMIER, a prospective registry of patients hospitalized with myocardial infarction. 16 Patients with a suspected AMI because of positive troponin or creatinine kinase-MB levels were screened for eligibility at 19 purposefully selected, nationally representative hospitals in the US between January 2003 and June 2004. 16 Consecutive patients meeting the following inclusion criteria were eligible for participation: greater than 18 years of age, presented directly to an enrolling institution or were transferred within 24 h of the onset of symptoms, had supporting evidence of AMI (ischemic signs and symptoms, including ST segment changes and elevation of cardiac enzymes), and consented to follow-up. Patients with elevated cardiac biomarkers secondary to medical complications and those admitted from penal facilities were not enrolled. Among eligible patients (n=10,911), nearly one-fourth (n=2,498) consented to the study. Differences between participants and nonparticipants have been reported elsewhere. 16 Enrollees had a complete chart abstraction, a baseline interview within 24 to 72 h of admission, and follow-up interviews at 1, 6, and 12 months. For these analyses patients were excluded if USOC could not be defined (n=23), if they expired in the hospital (n=17), or if they were discharged to hospice (n= 4), leaving a cohort of 2,454 patients.
Usual Source of Care
As there is no gold-standard or validated definition of USOC relationships, we created a continuum categorization scheme. We first conceptualized USOC using the single, standard question, "Do you currently have a doctor or care provider who you feel is primarily responsible for your health care?" dichotomizing responses into yes/no. The strength of the relationship was further assessed among adults reporting having a USOC using three additional questions. First, "How long have you been seeing this doctor/care provider?" (in years); responses of <2 years were assigned a score of 0 and ≥2 years a score of 1. The following two questions, "Does your doctor/care provider seem to know you and your medical condition well?" and "Is your doctor/ care provider or his/her staff good at following up with you on appointments and test results?" were graded on a 5-point Likert scale. We assigned a score of 0 to a response of "not at all"/"not very well"/"somewhat" and a score of 1 to a response of "fairly well"/"extremely well." If patients did not answer any of the three questions further quantifying the strength of their USOC, they were assigned a score of 0 for that question. Aggregate scores from these three questions were used to qualify the relationship. In our first iteration, a sum score of 0 was categorized as "weak," 1 as moderate, and 2-3 as strong. Given sample size concerns, we combined the "weak" and "moderate" categories (scores 0-1) and labeled the USOC as "weak."
Construct Validity and Reliability. We conducted exploratory analyses to determine whether our definition for USOC strength measured a distinct aspect that reflected the quality of the relationship, not the mere presence or accessibility of a USOC, or frequency of visits with a USOC. We examined the proportion of patients who followed up with a USOC and the frequency of visits in the 6 months following hospitalization. As hypothesized, attendance to follow-up visits at 6 months (no USOC 33 %; weak USOC 56 %, strong USOC 55 %) and frequency of follow-up (mean visits: no USOC=2.2; weak USOC=2.6; strong USOC=2.6) differed by the presence of a USOC, but not by the strength of the relationship, suggesting that USOC relationships capture more than visit history and are indicative of the quality of the interactions at those visits. We also examined access and financial barriers to establishing a USOC, to determine their independence from the association between USOC strength and the main outcomes. Access and financial barriers are further described below.
In a sensitivity analysis, we tested other definitions of USOC to determine whether a consistent dose-response relationship exists between USOC strength and mortality. For these analyses, we first examined the standard USOC definition of present versus not present. In a second iteration, the USOC relationship was categorized as "weak" or "strong" by summing the Likert scores of the above two questions on a scale of 2-10, assigning scores of 2-4 as "weak USOC" and scores of 5-10 as "strong USOC." In a third iteration, we used the previously mentioned four-level categorization of USOC-none/weak/moderate/strong.
Main Outcome Measures
We assessed all-cause mortality within 6 months and 12 months of hospitalization. We also assessed all-cause readmission to any hospital within 6 months and 12 months of hospital discharge. Readmission was assessed through a phone interview with the patient 6 months and 12 months after index hospitalization. Mortality was assessed by crossreferencing patients' Social Security numbers with the Social Security Master Death File. 17 
Other Variables of Interest
Additional information was collected on all participants during the baseline interview. Socio-demographic characteristics included age, sex, race/ethnicity, education level, and marital status. We categorized monthly financial situation as: "some money left over," "just enough to make ends meet," or "not enough to make ends meet" (instead of income level, for which 29 % of the sample was missing data due to patients' refusal to answer the question). We also assessed other aspects of the financial situation related to utilization of health care, including: "avoided medications due to cost," "avoided getting health care due to cost," and "medication costs have become an economic burden." Health care coverage referred to primary payor type. We specifically asked about insurance coverage for medications and difficulty getting care when needed. Clinical characteristics included family history of coronary artery disease along with prior angina, AMI, percutaneous coronary intervention, coronary artery bypass graft, and congestive heart failure. Non-cardiac clinical characteristics included smoking status, chronic lung disease, hypertension, hyperlipidemia, chronic renal failure, peripheral arterial disease, and diabetes mellitus. We assessed AMI severity using a validated 6-month mortality prediction scale, the GRACE score. 18 We assessed five performance measures of in-patient quality of care that were captured through chart abstraction: aspirin at arrival, aspirin at discharge, beta-blocker at arrival, beta-blocker at discharge, and ACE inhibitor/ angiotensin receptor blocker for left ventricular systolic function upon discharge. We also assessed discharge planning among the three groups including whether the patient indicated he/she received instructions for cardiac rehabilitation, diet and exercise counseling, lipid assessment, and smoking cessation counseling.
To distinguish the quality of relationships with a care provider from issues related to barriers and access, we explored utilization of care in the month following hospitalization using data from 1-month follow-up phone interviews. We looked at attendance to follow-up appointments with a cardiologist, cardiac surgeon, and/or primary care physician. We additionally analyzed whether patients experienced difficulty getting needed medical care and whether finances played a role in their follow-up care at 1 month, assessing: reasons patients had difficulty getting medical care, whether the patient had insurance coverage for medications, whether they were not taking a medication because of cost, and whether the costs of medical care had become a burden, which we hypothesized may have been different from baseline responses because of the potential increased medical needs after having suffered an AMI.
Statistical Analysis
We compared baseline characteristics among participants with USOC (categorized as none, weak, or strong) using the Mantel-Haenszel trend test for categorical variables and the linear trend test for continuous variables. Cox proportional hazard models were used to assess the association between USOC and 6-and 12-month mortality and readmission. All models were adjusted for patients' baseline health status and accounted for clustering of observations by site using sitestratified proportional hazard regression. In the calculation of the hazard ratio, we used strong USOC as the reference.
To assess the independent association between USOC and outcomes, multivariable models were built, first unadjusted, and then fully adjusting for patient characteristics. Variables were considered as candidates for inclusion in the model if they differed significantly across USOC levels, were not highly correlated with one another, and had a sufficient number of events per variable (≥20). 19, 20 The final variables adjusted for in the model included demographic variables (age, sex, race/ethnicity, education level, marital status), socioeconomic factors (financial situation, avoided medication due to cost, insurance payor), and clinical characteristics (family history of CAD, prior angina, AMI, PCI, CABG, CHF, smoker, chronic lung disease, hypertension, hyperlipidemia, chronic renal failure, peripheral arterial disease, diabetes mellitus, and GRACE score). We report results from the unadjusted and fully adjusted analyses. As a secondary analysis to examine the robustness of our results, we conducted a propensity score analysis, estimating the propensity of having no USOC, a weak USOC relationship, or a strong USOC relationship. Propensity scores were used as covariates of adjustment in our models.
Missing information for one or more covariates was minimal, with only 1.2 % missing more than one value for analysis. All analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC) and R version 2.11.1 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Baseline Characteristics
In our sample of 2,454 patients admitted for AMI, 441 (18.0 %) reported no USOC, 247 (10.0 %) reported a weak USOC, and 1,766 (72.0 %) reported a strong USOC (Table 1) . In general, those with no USOC and lower quality USOC were younger, non-Caucasian, less often married, less educated, poorer, and had fewer cardiac and non-cardiac comorbidities. As compared with patients with a strong USOC, patients with weak USOC and no USOC were less likely to have prior PCI or CABG (35.4 % vs. 25.9 % vs. 14.5 %, p<0.001, respectively), CHF (13.3 % vs. 10.1 % vs. 7.0 %, p<0.001), diabetes (32.1 % vs. 24.3 % vs. 17.9 %, p<0.001), chronic lung disease (14.7 % vs. 9.3 % vs. 8.8 %, p<0.001), and peripheral artery disease (8.8 % vs. 7.3 % vs. 3.6 %, p<0.001). In addition, they had lower GRACE scores, indicative of less severe AMIs. There were no differences in five quality of care measures, including receipt of aspirin on arrival (98.1 % vs. 95.0 % vs. 96.2 %, p=0.11) and at discharge (93.2 % vs. 94.4 % vs. 93.4 %, p=0.98), receipt of beta-blocker on arrival (92.8 % vs. 93.8 % vs. 91.1 %, p=0.17) and at discharge (90.5 % vs. 92.7 % vs. 91.8 %, p=0.51), and receipt of ACE inhibitors/angiotensin receptor blockers at discharge for patients with left ventricular systolic dysfunction (84.9 % vs. 83.9 % vs. 79.0 %, p=0.13).
At the time of discharge, patients reporting no, weak, and strong USOC had similar outpatient care plans for follow-up (Table 1) . In addition, patients reporting no USOC were as likely as patients with a weak or strong USOC to receive referrals for cardiac rehabilitation, a lipid assessment, and diet counseling. They were less likely to receive exercise counseling but more likely to receive smoking cessation counseling.
Follow-up Care
At 1-month follow-up (Table 2 ), a similar percentage of patients reporting no, weak, and strong USOC had attended an appointment with a cardiologist (31.8 %, 34.3 %, and 32.7 %, p=0.85), though patients with no USOC were less likely to attend a scheduled visit with a primary care provider than patients with weak or strong USOC (31.5 %, 44.8 %, and 49.8 %, p<0.001). Additionally, patients with no USOC were more likely than patients with weak or strong USOC to report avoiding medical care because of cost, to have less insurance coverage for medications, and to report that medical costs were becoming an economic burden.
Mortality Post-Discharge After AMI
Among patients reporting no, weak, and strong USOC, 6-month mortality rates were 5.9 %, 5.7 %, and 4.4 %, respectively (Table 3) . In unadjusted analyses, the 6-month mortality rates were higher, but not significantly different, among patients with no USOC [hazard ratio (HR)=1.36, 95 % CI, 0.88-2.13, p=0.17] and with a weak USOC (HR= 1.30, 95%CI, 0.74-2.29, p=0.37) when compared with patients with a strong USOC. In multivariable analysis, when compared with self-reporting a strong USOC, selfreporting no USOC was associated with higher 6-month mortality rates [adjusted HR (aHR)=3.15, 95 % CI, 1.79-5.52; p<0.001], while a weak USOC trended toward being associated with higher 6-month mortality rates (aHR=1.95, 95 % CI, 0.98-3.88; p=0.06).
Among patients reporting no, weak, and strong USOC, 12-month mortality rates were 6.9 %, 7.3 %, and 7.1 %, respectively. In unadjusted analyses, the 12-month mortality rates were no different among patients with no USOC (HR= 0.98, 95 % CI, 0.66-1.46, p=0.93) and with a weak USOC (HR=1.04, 95 % CI, 0.64-1.71, p=0.87) when compared with patients with a strong USOC. In multivariable analysis, when compared with self-reporting a strong USOC, self-reporting no USOC was associated with higher 12-month mortality rates (aHR=1.92, 95 % CI, 1.19-3.12; p=0.01), whereas selfreporting a weak USOC was not significantly associated with higher 12-month mortality rates (aHR=1.43, 95 % CI, 0.80-2.55; p=0.23). In a sensitivity analysis examining several different definitions of USOC strength, we found similar trends (Appendix 1; available online). Additional secondary analyses adjusting for propensity scores for presence and strength of USOC relationship were also not substantively different (Appendix 2; available online).
Readmission Post-Discharge After AMI
Among patients reporting no, weak, and strong USOC, 6-month readmission rates were 27.5 %, 32.6 %, 29.4 %, respectively (Table 4) . In unadjusted analyses, the 6-month readmission rates were no different among patients with no USOC (HR=0.90, 95 % CI, 0.72-1.11, p=0.32) and with a weak USOC (HR=1.16, 95% CI, 0.90-1.49, p=0.25) when compared with patients with a strong USOC. In multivariable analysis, when compared with self-reporting a strong USOC, self-reporting no USOC was not associated with higher 6-month readmission rates (aHR=1.05, 95 % CI, 0.82-1.35; p= 0.71); similarly, there was no association between self-reporting a weak USOC and higher 6-month readmission rates (aHR= 1.15, 95 % CI, 0.87-1.53; p=0.32). Numbers may not sum to column total because of missing data, and percentages may not sum to 100 % because of rounding SD standard deviation, PPO preferred provider organization, HMO health maintenance organization, CAD coronary artery disease, AMI acute myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CHF congestive heart failure, ARB angiotensin receptor blocker, LVSD left ventricular systolic dysfunction *GRACE Score associated with 6-month mortality risk. The higher the score, the greater the risk Among patients reporting no, weak, and strong USOC, 12-month readmission rates were 38.1 %, 40.3 %, and 40.3 %, respectively. In unadjusted analyses, the 12-month readmission rates were no different among patients with no USOC (HR=0.92, 95 % CI, 0.76-1.10, p=0.35) and with a weak USOC (HR=1.05, 95 % CI, 0.84-1.32, p=0.68) when compared with patients with a strong USOC. In multivariable analysis, when compared with self-reporting a strong USOC, self-reporting no USOC was not associated with higher 12-month readmission rates (aHR=1.04, 95 % CI, 0.83-1.29; p=0.74); likewise, adults self-reporting a weak USOC did not have higher 12-month readmission rates (aHR=1.08, 95 % CI, 0.84-1.38; p=0.56). Again, secondary analyses adjusting for propensity scores for the presence and strength of the USOC relationship were not substantively different (Appendix 2; available online).
DISCUSSION
In our prospective, multicenter study of patients hospitalized with AMI in 2003 and 2004, we observed a significant association between the presence and strength of a USOC relationship at the time of admission and mortality after AMI, as there was a two-fold greater adjusted mortality observed among patients with a weak USOC and a statistically significant three-fold greater adjusted-mortality at 6 months among patients with no USOC. This pattern persisted at 1 year, although the strength of the relationship diminished, potentially reflecting patient's establishment of regular care and changes in the strength of this relationship following AMI.
We did not observe an association between USOC and readmission. This is contrary to our hypothesis that patients with no or weak USOC would have more hospitalizations than patients with strong USOC, having fewer opportunities to treat symptoms or prevent disease progression. 21, 22 It may have been the case, however, that patients with strong USOC utilize greater amounts of health care overall, including more hospitalizations. 23, 24 Nonetheless, our data suggest that weaker USOC is associated with worse mortality and can help identify higher risk patients warranting increased efforts to establish a higher quality USOC, although this hypothesis will need to be tested in future studies.
Nearly 20 % of patients in our study did not have a USOC, and these patients had the highest mortality risk. There are several potential explanations for this observation, including differences in baseline risk, in-hospital AMI care, and post-discharge follow-up care. Our data suggest that in-hospital care was similar across USOC groups and that the increased mortality risk may be incurred either before or after hospitalization. We know from prior literature that patients with no USOC are less likely to receive preventive care and effective disease management. [10] [11] [12] In our population, with the exception of smoking, patients with no or weak USOC were less likely to have traditional risk factors for coronary artery disease, Numbers may not sum to 100 % because of missing data which may reflect a true lower prevalence of disease or under-diagnosis and hence missed opportunities for risk factor control. It is also interesting to note that among patients with a strong USOC, 35 % had prior PCI or CABG, as compared with only 15 % of patients with no USOC and 26 % of patients with a weak USOC. While this seems intuitive, as patients with more complex disease and prior interventions have more opportunities to establish relationships with a provider, our data also demonstrate that patients with no USOC reported greater difficulty getting needed medical care. Thus, it remains unknown whether the lower prevalence of revascularization among patients with no or weak USOC again reflects a lower prevalence of prior coronary artery disease or less detection and poorer access to needed revascularization procedures. These important differences in baseline risk stratification and treatment may explain the increased mortality associated with patients with no or weak USOC. Post-discharge care may also have been very different for these USOC groups, despite having similar discharge plans. During the most vulnerable time, 1-month following AMI, only one-third of patients with no prior USOC attended a visit with a primary care provider as compared with nearly half in the weak and strong USOC groups. Interestingly, among all groups, only one-third attended a visit with a cardiologist in the month following AMI despite over 70 % of the patients having scheduled appointments. While there are no absolute guidelines on the timing and frequency of follow-up care after AMI, it seems reasonable to assume that this was not sufficient, at least for some patients. Specifically, patients with no and weak USOC were more likely to report difficulty getting care when needed and avoiding medical care because of cost. Collectively, these data suggest that access to affordable health care remains a significant problem even after having a major event such as an AMI and may result in fewer opportunities for prevention and intervention.
There are some potential limitations to consider in the interpretation of this study. First, our objective was to determine the association of baseline USOC with longterm outcomes following AMI. In doing so, we developed a definition to qualify the strength of the relationship, which has not been validated. However, in sensitivity analyses using different cutpoints to distinguish weak from strong USOC relationships, we found similar 'dose-response' relationships with 12-month mortality. Second, patients reporting a strong USOC had more comorbid disease at baseline. Although we adjusted our analyses for these differences in comorbidities, illness burden may have been underdiagnosed in patients without a USOC and thus may have underestimated the true burden of disease in this group. Nonetheless, this would have biased our results to the null. Finally, unmeasured differences between patients can confound all observational analyses. However, in this unique registry, we had very rich data on access to care and financial barriers, factors that would be expected to impact our findings and for which we were able to adjust using both multivariable and propensity score analyses.
In conclusion, having a strong USOC was associated with lower mortality after AMI, while a weak USOC had only slightly lower mortality than patients with no USOC. These Adjusted for age, marital status, sex, race/ethnicity, education level, financial situation, avoided medication because of cost, payor, family history of CAD, prior angina, prior AMI, prior PCI, prior CABG, CHF, smoker, chronic lung disease, hypertension, hyperlipidemia, chronic renal failure, peripheral arterial disease, diabetes mellitus, and GRACE score More studies are needed, however, to understand the nature of this association and whether supporting highquality relationships with clinicians/health centers will lead to improved outcomes for patients following AMI.
